Nicolas Mottet

Tranexamic Acid for the Prevention of Blood Loss after Cesarean Delivery

Marie Victoire Sénat, Maëla Le Lous, Norbert Winer et al. · New England Journal of Medicine · 2021 · 258 citations · Full text

Randomized Phase III Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin, or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients with Muscle-invasive Bladder Cancer. Analysis of the GETUG/AFU V05 VESPER Trial Secondary Endpoints: Chemotherapy Toxicity and Pathological Responses

Christian Pfister, Gwénaëlle Gravis, Aude Fléchon et al. · European Urology · 2020 · 238 citations · Full text

Urology, Genitourinary Cancer, Chemotherapy Toxicity +7

Maternal outcomes and risk factors for COVID-19 severity among pregnant women

Manon Vouga, Guillaume Favre, Óscar Martínez Pérez et al. · Scientific Reports · 2021 · 144 citations · Full text

Pregnancy Disorders, Reproductive Health, Preterm Birth Prediction +23

Perioperative dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin in muscle-invasive bladder cancer (VESPER): survival endpoints at 5 years in an open-label, randomised, phase 3 study

Christian Pfister, Gwénaëlle Gravis, Aude Fléchon et al. · The Lancet Oncology · 2023 · 77 citations

Survival Endpoints, Surgical Oncology, Urology +7

Maternal and perinatal outcomes following pre-Delta, Delta, and Omicron SARS-CoV-2 variants infection among unvaccinated pregnant women in France and Switzerland: a prospective cohort study using the COVI-PREG registry

Guillaume Favre, Émeline Maisonneuve, Léo Pomar et al. · The Lancet Regional Health - Europe · 2023 · 65 citations · Full text